Lakefront Biotherapeutics NV (GXE)
XTRA • GXE • BE0003818359
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 0.4% of free float sold short, 204.5 days to cover, cost to borrow 2.1%. Sign up for live short interest data.
Market Cap
2.13b USD | # 3800 in DE
Volume
744 shares | 2.89m USD
Shares Outstanding
64.12m
Free Float Shares
66.70% | 42.77m
